HR 124 · In committee · last action January 3, 2025
<p><strong>Byron Nash Renal Medullary Carcinoma Awareness Act of </strong><strong>2023 [<em>sic</em>]</strong></p><p>This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)</p>
Al Green (D-TX)
No votes recorded against this bill yet — vote coverage is a work in progress.
<p><strong>Byron Nash Renal Medullary Carcinoma Awareness Act of </strong><strong>2023 [<em>sic</em>]</strong></p><p>This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)</p>